No siempre a cada síntoma le corresponde un daño | 29 ABR 22

Síntomas, placebo y cerebro bayesiano

A pesar de su éxito, el modelo biomédico no ha proporcionado una explicación adecuada de dos fenómenos bien demostrados: los síntomas sin alteración fisiopatológica y el alivio después de la administración de un placebo.
Autor/a: Ongaro, Giulioa, Kaptchuk, Ted J. Fuente: Pain: doi: 10.1097/j.pain.0000000000001367 Topical Review Symptom perception, placebo effects, and the Bayesian brainOngaro, Giulioa,*; Kaptchuk, Ted J.b,c
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas
  1. Anchisi D, Zanon MA. Bayesian perspective on sensory and cognitive integration in pain perception and placebo analgesia. PLoS One 2015;10:e0117270.
  2. Barrett LF, Simmons WK. Interoceptive predictions in the brain. Nat Rev Neurosci 2015;16:419–29.
  3. Benedetti F, Lanotte M, Lopiano L, Colloca L. When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience 2007;147:260–71.
  4. enedetti F, Maggi G, Lopiano L, Lanotte M, Rainero I, Vighetti S, Pollo A. Open versus hidden medical treatments: the patient's knowledge about a therapy affects the therapy outcome. Prev Treat 2003;6:1a.
  5. Benedetti F, Carlino E, Pollo A. Hidden administration of drugs. Clin Pharmacol Ther 2011;90:651–61.
  6. Brown H, Adams RA, Parees I, Edwards M, Friston K. Active inference, sensory attenuation and illusions. Cogn Process 2013;14:411–27.
  7. Büchel C, Geuter S, Sprenger C, Eippert F. Placebo analgesia: a predictive coding perspective. Neuron 2014;81:1223–39.
  8. Carvalho C, Caetano JM, Cunha L, Rebouta P, Kaptchuk TJ, Kirsch I. Open-label placebo treatment in chronic low back pain: a randomized controlled trial. PAIN 2016;157:2766.
  9. Clark A. Whatever next? Predictive brains, situated agents, and the future of cognitive science. Behav Brain Sci 2013;36:181–204.
  10. Clark A. Surfing uncertainty: prediction, action, and the embodied mind. Oxford: Oxford University Press, 2015.
  11. Colagiuri B, Quinn VF, Colloca L. Nocebo hyperalgesia, partial reinforcement, and extinction. J Pain 2015;16:995–1004.
  12. Colloca L, Benedetti F. Placebo analgesia induced by social observational learning. PAIN 2009;144:28–34.
  13. Edwards MJ, Adams RA, Brown H, Parees I, Friston KJ. A Bayesian account of “hysteria”. Brain 2012;135:3495–512.
  14. Espay AJ, Norris MM, Eliassen JC, Dwivedi A, Smith MS, Banks C, Allendorfer JB, Lang AE, Fleck DE, Linke MJ, Szaflarski JP. Placebo effect of medication cost in Parkinson disease a randomized double-blind study. Neurology 2015;84:794–802.
  15. Friston K, Shiner T, Fitzgerald T, Galea JM, Adams R, Brown H, Dolan RJ, Moran R, Stephan KE, Bestmann S. Dopamine, affordance and active inference. PLoS Comput Biol 2012;8:e1002327.
  16. Geuter S, Koban L, Wager TD. The cognitive neuroscience of Placebo effects: concepts, predictions, and physiology. Annu Rev Neurosci 2017;40:167–88.
  17. Grahl A, Onat S, Büchel C. The periaqueductal gray and Bayesian integration in placebo analgesia. Elife 2018;7:e32930.
  18. Hechler T, Endres D, Thorwart A. Why harmless
 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Contenidos relacionados
Los editores le recomiendan continuar con las siguientes lecturas:
AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2022